Speaker illustration

Mrs Marianne Lachaux

INSERM U1096, Rouen (France)

Acute imeglimin treatment improves metabolic syndrome-related cardiac and coronary endothelial dysfunction in the zucker fa/fa rat

Event: ESC Congress 2018

Topic: Antidiabetic Pharmacotherapy

Session: Best Posters in cardiovascular remodelling

Thumbnail

Short- and long-term imeglimin treatment reduces metabolic syndrome-related diabetic cardiomyopathy

Event: ESC Congress 2017

Topic: Diastolic dysfunction

Session: Chronic heart failure (CHF)

Thumbnail

Improved metabolic syndrome-related right and left ventricular dysfunction by the dual ETA-ETB receptor antagonist macitentan.

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Pulmonary hypertension

Session: Basic science - Animal experimentation

Thumbnail